title: [Low molecular weight heparin decreases thrombosis risk in patients receiving chemotherapy for cancer].
authors.affiliation: Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstrasse 74, Dresden, Germany. Steven.Heller@uniklinikum-dresden.de
authors.forename: S
authors.initials: S
authors.lastname: Heller
authors.forename: M
authors.initials: M
authors.lastname: Krause
mesh_terms: D004311:Double-Blind Method; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011655:Pulmonary Embolism / Q000139:chemically induced* / Q000517:prevention & control*; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000139:chemically induced* / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; C569346:semuloparin